<DOC>
	<DOCNO>NCT02562950</DOCNO>
	<brief_summary>This drug-drug interaction study evaluate effect multiple oral dos GLPG1837 single dose pharmacokinetic profile midazolam administer feed healthy male subject . Each subject receive single oral dose midazolam ( 2 mg ) 2 occasion : Day 1 , dose GLPG1837 Day 12 co-administered GLPG1837 , multiple oral dos GLPG1837 ( daily 10 day , Day 2 Day 11 ) . Also , safety tolerability multiple oral dos GLPG1837 co-administered midazolam healthy male subject evaluate . A first dose group 12 subject receive total daily dose 500 mg ( 250 mg b.i.d . ) GLPG1837 second dose group 12 subject receive total daily dose 1000 mg ( 500 mg b.i.d . ) GLPG1837 .</brief_summary>
	<brief_title>A Phase I , Open Interaction Study Between GLPG1837 Midazolam Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>healthy male , age 1850 year BMI 1830 kg/m2 Any condition might interfere procedure test study Drug alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>